Carregant...
The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortality
Hyperuricaemia is frequent in chronic kidney disease (CKD). Observational studies have shown an association with adverse outcomes and acquired hyperuricaemia (meaning serum urate levels as low as 1.0 mg/dL) in animal models induces kidney injury. This evidence does not justify the widespread use of...
Guardat en:
| Publicat a: | Clin Kidney J |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7769546/ https://ncbi.nlm.nih.gov/pubmed/33391737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfaa236 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|